About Biogen Inc.

Biogen Inc. (NASDAQ: BIIB) is a Healthcare company (Drug Manufacturers - General) with a market capitalization of $35.6B. Its Maz Rating is 4.30 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 2.60, Growth 2.18, Profitability 4.84, Financial Health 3.00, Momentum 4.43 (as of 2026-10-16).

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NASDAQ

Country

US

CEO

Christopher A. Viehbacher

Employees

7,500

IPO date

1991-09-17